ライフサイエンスコーパス: growth hormone deficiency

1 timum for bone health of adult patients with growth hormone deficiency.

2 hthalmia, hypogonadotrophic hypogonadism and growth hormone deficiency.

3 0.02) standard deviation scores in isolated growth hormone deficiency.

4 uate nutrition, insulin unresponsiveness, or growth hormone deficiency.

5 xperience with growth hormone replacement of growth hormone deficiency.

6 expanded beyond the realm of replacement for growth hormone deficiency.

7 ; these impairments were not associated with growth hormone deficiency.

8 th-related disorders, such as acromegaly and growth hormone deficiency.

9 node architecture, and short stature due to growth hormone deficiency.

10 The most common endocrine disorders were growth hormone deficiency (12.5%), precocious puberty (1

11 ndocrine disorders such as hypothyroidism or growth hormone deficiency (44%), subsequent neoplasms su

12 dy aimed to quantify risk factors for SAH or growth hormone deficiency among CCS.

13 wth hormone for the treatment of adults with growth hormone deficiency and conditions such as Turner'

14 h whole-genome resequencing in patients with growth hormone deficiency and maternally inherited gingi

15 crinology clinic where he was diagnosed with growth hormone deficiency and was started on replacement

16 with adrenocorticotropic hormone deficiency, growth hormone deficiency, and mild ectodermal dysplasia

17 mononeuropathies and mild distal neuropathy, growth hormone deficiency, and mild mental retardation w

18 he regulation of human growth, and show that growth hormone deficiency associated with maternally inh

19 hormone administered to men with adult-onset growth hormone deficiency at a dose adjusted according t

20 Pituitary hormone deficiencies, with Growth Hormone deficiency being most frequent (1 in 3,50

21 Individual growth hormone deficiencies can develop after a dose as

22 ciency syndrome include doubts about whether growth hormone deficiency causes increased morbidity and

23 We identified growth hormone deficiency, central diabetes insipidus, a

24 es associated with the phenotype of isolated growth hormone deficiency, combined pituitary hormone de

25 to valvular aortic stenosis, acromegaly, or growth hormone deficiency, conditions associated with al

26 or older and had an established diagnosis of growth hormone deficiency, either alone or with multiple

27 ment on fracture risk in adult patients with growth hormone deficiency exist.

28 treatment on fracture risk in patients with growth hormone deficiency from the international Hypopit

29 Growth hormone deficiency (GHD) after radiation therapy

30 Growth hormone deficiency (GHD) after TBI may impair axo

31 thyroid function and stimulation testing for growth hormone deficiency (GHD), and adrenocorticotropin

32 nts were treated with rhGH owing to isolated growth hormone deficiency (GHD), small for gestational a

33 ic reesterification, and a high frequency of growth hormone deficiency (GHD).

34 opy were significantly lower in the isolated growth hormone deficiency group.

35 mpared with controls, children with isolated growth hormone deficiency had lower Full-Scale IQ (P < 0

36 Growth hormone as therapy for adults with growth hormone deficiency has not been universally accep

37 Patients with adult-onset growth hormone deficiency have reduced bone density and

38 yroid cancer (HR, 9.2; 95% CI, 6.2 to 13.7), growth hormone deficiency (HR, 5.3; 95% CI, 4.3 to 6.4),

39 Survivors had significantly more growth hormone deficiency, hypogonadism, and neuropathy

40 se in weight Z: score and the development of growth-hormone deficiency, hypothyroidism, hypogonadism,

41 e treatment are now required to confirm that growth hormone deficiency impacts significantly on brain

42 ant human growth hormone in the treatment of growth hormone deficiency is well established.

43 , the suggestion has emerged that endogenous growth-hormone deficiency might account for any excess m

44 growth but little is known of the effect of growth hormone deficiency on brain structure.

45 Growth hormone deficiency or hypothyroidism were not obs

46 sm (OR, 3.27, 95% CI, 2.35-4.55; AF, 25.1%), growth hormone deficiency (OR, 5.28, 95% CI, 3.68-7.56;

47 pothyroidism, hypogonadotropic hypogonadism, growth hormone deficiency, or arginine vasopressin defic

48 Children with isolated growth hormone deficiency (peak growth hormone <6.7 micr

49 ildren (mean 8.8 years of age) with isolated growth hormone deficiency [peak growth hormone <6.7 micr

50 se progressed, including diabetes insipidus, growth hormone deficiency, primary hypogonadism, adrenal

51 Familial growth hormone deficiency provides an opportunity to ide

52 syndrome, coeliac disease, cystic fibrosis, growth hormone deficiency, renal tubular acidosis, and s

53 ocus, in a large family in which an isolated growth hormone deficiency segregates as an autosomal dom

54 oking, sedentary behavior, hypogonadism, and growth hormone deficiency, suggest feasible targets for

55 available and approved for treatment of the growth hormone deficiency syndrome in adults.

56 cism about the use of growth hormone for the growth hormone deficiency syndrome include doubts about

57 expensive agents for certain aspects of the growth hormone deficiency syndrome, especially cardiovas

58 placement therapy for patients with definite growth hormone deficiency--that is, patients with sympto

59 he majority of mutations that cause isolated growth hormone deficiency type II are the result of aber

60 this prospective cohort study, patients with growth hormone deficiency were analysed from the HypoCCS

61 In patients with isolated growth hormone deficiency, white matter abnormalities in

62 ive against fracture for adult patients with growth hormone deficiency without previously reported os